Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Stroke. 2011 Jun 30;42(8):2257–2262. doi: 10.1161/STROKEAHA.111.615682

Figure 3. Results of probabilistic sensitivity analysis: incremental cost-effectiveness scatter plot.

Figure 3

Incremental effectiveness is measured in QALYs. The dotted diagonal line represents the willingness to pay threshold of $50,000 per QALY. All points to the right of the willingness to pay line are considered cost-effective. Each point represents a simulation run. The dark square represents the base case result (0.28 QALYs gained at an incremental cost of $6,050).